A Case Management Intervention to Prevent ER Visits in HIV-infected Persons

This study has been terminated.

(Intervention was taken up as a standard of care.)

Sponsor:

Information provided by (Responsible Party):

University of California, San Francisco

ClinicalTrials.gov Identifier:

NCT00187590

First received: September 13, 2005

Last updated: January 21, 2014

Last verified: January 2014

History of Changes

Purpose

Case management has become an integral part of HIV care. There is little science however demonstrating its effectiveness. This is a randomized, controlled trial of a phone call intervention after an ER visit to see if this can reduce further ER visits, hospitalizations, deaths, and cost.

Condition	Intervention
HIV	Behavioral: Case manager phone call after an ER visit


Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS

U.S. FDA Resources

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:

Death, hospitalizations, ER visits, LOS [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Cost [ Time Frame: 1 year ] [ Designated as safety issue: No ]


Enrollment:	612
Study Start Date:	April 2004
Study Completion Date:	January 2013
Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Intervention Phone call after an ER visit.	Behavioral: Case manager phone call after an ER visit
No Intervention: Control No phone call after an ER visit.

Detailed Description:

One year retrospective look at outcome measures followed by a one year trial of a phone call after each ER visit in half of the group. Outcomes measured are cost, ER visits, hospitalizations, death, length of stay. Adults only, English or Spanish, questionnaire on depression, appointments, drug use with referral to case management services, drug rehab services, or followup appointments. Time for intervention is recorded to estimate cost.

Eligibility


Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patient in our clinic as of 4-1-04

Exclusion Criteria:

<18 years old

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00187590

Locations


United States, California
University Medical Center
Fresno, California, United States, 93702

Sponsors and Collaborators

University of California, San Francisco

Investigators


Principal Investigator:	Roger B Mortimer, MD	UCSF-Fresno Medical Eduction Program

More Information

No publications provided


Responsible Party:	University of California, San Francisco
ClinicalTrials.gov Identifier:	NCT00187590 History of Changes
Other Study ID Numbers:	UMC200517
Study First Received:	September 13, 2005
Last Updated:	January 21, 2014
Health Authority:	United States: Food and Drug Administration

Keywords provided by University of California, San Francisco:


HIV case management

ClinicalTrials.gov processed this record on March 02, 2015

To Top